Breaking News on Contract Research, Manufacturing & Clinical Trials

Headlines > March 2017

« Previous month

Marken obtains two operating licenses in Argentina

22-Mar-2017 - Marken has secured two new operating licenses in Argentina, allowing it to provide a full range of logistics services to the country’s clinical trial market.


Alcami launches new customer portal and mobile app

22-Mar-2017 - Alcami has launched a new customer portal and mobile application as part of its strategy to further diversify the company.


CDMOs outline new initiatives, investments at DCAT Week

21-Mar-2017 - Manufacturers are investing in capacity and technology to help close the “market gap” for services while expanding to new locations across the globe.


DCAT 17: Outsourcing-Pharma goes to New York

21-Mar-2017 - Didn't make it to New York, New York? Outsourcing-Pharma did and we bring you the best of Twitter from this CDMO-heavy event:

Envigo adding non-animal tech ahead of new regulations

20-Mar-2017 - Envigo is developing new In vitro tests in advance of the Comprehensive In Vitro Proarrhythmia Assay (CiPA) recommendations expected at the end of the year.

7 DHL stations to receive IATA CEIV pharma certifications in 2017

20-Mar-2017 - DHL Global Forwarding plans to certify seven US stations in the Americas throughout 2017 with the remaining global stations slated for certification by the end of the second quarter.

CROs form strategic alliance to provide end-to-end services

20-Mar-2017 - The strategic alliance between Metrion and Concept will provide clients with a fully integrated ion channel drug discovery service.

Fred Hutch to use Origin Sciences' OriCol in Ph I HIV study

16-Mar-2017 - Fred Hutchinson Cancer Research Center will use Origin Sciences’ novel mucosal sampling device, OriCol, for sample collection as part of a Phase I HIV study.

CRF Health: eConsent adoption to reach 82% by 2020

16-Mar-2017 - The industry can't be slow to adopt eConsent solutions as technology has become an integral part of modern clinical trials, says CRF Health. 


Charles River to pay $1.8m to settle overbilling claims

16-Mar-2017 - The US Justice Department has announced Charles River Laboratories International Inc. will pay the US government $1.8m to settle claims that it violated the False Claims Act.

News in brief

Veeva announces new product integration with Salesforce

15-Mar-2017 - Veeva Systems has announced new integration between Salesforce Marketing Cloud and Veeva CRM for increased visibility.

Celerion adds biometric fingerprint tech across units

15-Mar-2017 - Celerion has implemented Verified Clinical Trials’ (VCT) biometric fingerprint technology to address “significant amount” of participants dual enrolling at Ph I units.

Ideal Cures 'building business' with PE investment

15-Mar-2017 - Idea Cures has announced an investment from the global private equity firm, TA Associates, as it aims to grow its manufacturing business.

Heptares, Daiichi Sankyo to develop small molecules for pain treatment

15-Mar-2017 - Heptares Therapeutics has entered into a drug discovery and licensing agreement with Daiichi Sankyo – providing further validation of the company’s structure-based drug design approach, says CEO.

Cytel: model-informed drug development expanding area of focus

14-Mar-2017 - Cytel Inc. has established a dedicated quantitative pharmacology and pharmacometrics team to meet an increasing demand for model-informed drug development from biopharma clients.

FDA commissioner nominee would be a 'strong partner,' says ACRO

14-Mar-2017 - Last week, President Donald Trump announced Scott Gottlieb as his nomination for the new US FDA commissioner – a candidate that ACRO says, “understands the complexities of drug development.”

Charles River re-ups Chiesi drug discovery contract

13-Mar-2017 - Charles River Laboratories has extended its integrated respiratory program with Chiesi Farmaceutici, through which it identifies and tests candidates for preclinical development.

Hot and cold? Analysts unpack CRO market expectations

13-Mar-2017 - A recent CRO market report  from ISR projects increasing outsourcing, though analysts remain less optimistic moving into 2017.

SRI secures $90m BARDA contract

13-Mar-2017 - SRI International will advance compounds with the potential to treat persons exposed to biological, radiation, nuclear, and chemical agents – in a deal worth up to $90m.

PCI triples serialization capacity as 'crunch time' commences

13-Mar-2017 - PCI Pharma Services has tripled its serialization capacity ahead of US DSCSA and EU FMD deadlines with follow-on investments planned to finalize its serialization infrastructure.

Novartis unit to consolidate Slovenian logistics in Kuehne + Nagel deal

13-Mar-2017 - Novartis subsidiary Lek Pharmaceuticals will consolidate its Slovenian logistics and warehousing operations from 10 sites to one.

SGS to operate Ph I inpatient clinical trials at Budapest hospital

09-Mar-2017 - SGS has signed a partnership agreement under which it will operate a dedicated clinical pharmacology unit for conducting Ph I inpatient clinical trials in Budapest, Hungary.

News in brief

Certara expands PBPK simulator availability

09-Mar-2017 - Certara has developed a new licensing approach, which provides smaller organizations access to its physiologically-based pharmacokinetic (PBPK) modeling and simulation platform.

CRO insourcing to gain momentum, says NovAliX

09-Mar-2017 - NovAliX has signed an insourcing agreement with UCB Biopharma, a model that the CRO says “energizes scientific organization” and offers "significant" cost advantages. 

Nicox resubmits AC-170 NDA after API supplier resolves GMP issues

09-Mar-2017 - Nicox S.A. has resubmitted AC-170, its conjunctivitis associated itching drug candidate, for US FDA review after its API supplier resolved the problems that saw the agency reject the New Drug...

« Previous month

Key Industry Events